Robert A. Sandhaus

6.0k total citations · 1 hit paper
118 papers, 4.0k citations indexed

About

Robert A. Sandhaus is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert A. Sandhaus has authored 118 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cancer Research, 53 papers in Pulmonary and Respiratory Medicine and 34 papers in Oncology. Recurrent topics in Robert A. Sandhaus's work include Protease and Inhibitor Mechanisms (59 papers), Peptidase Inhibition and Analysis (33 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers). Robert A. Sandhaus is often cited by papers focused on Protease and Inhibitor Mechanisms (59 papers), Peptidase Inhibition and Analysis (33 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers). Robert A. Sandhaus collaborates with scholars based in United States, Ireland and United Kingdom. Robert A. Sandhaus's co-authors include Edwin K. Silverman, James K. Stoller, Charlie Strange, Gerard Turino, Peter M. Henson, James Stocks, Noel G. McElvaney, G. Scott Worthen, Michael Campos and Christopher Haslett and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Robert A. Sandhaus

113 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

2015 325 citations Kenneth R. Chapman, Jonathan Burdon et al. profile →

Peers

Countries citing papers authored by Robert A. Sandhaus

Since Specialization

Citations

This map shows the geographic impact of Robert A. Sandhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Sandhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Sandhaus more than expected).

Fields of papers citing papers by Robert A. Sandhaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Sandhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Sandhaus. The network helps show where Robert A. Sandhaus may publish in the future.

Co-authorship network of co-authors of Robert A. Sandhaus

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Sandhaus. A scholar is included among the top collaborators of Robert A. Sandhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Sandhaus. Robert A. Sandhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Severe Obesity is Associated With Poor Health Outcomes in Alpha-1 Antitrypsin Deficiency-associated COPD 2025 ·American Journal of Respiratory and Critical Care Medicine ·Radmila Choate, Kristen E. Holm, Robert A. Sandhaus, David M. Mannino, Charlie Strange	0
2	Analysis of alpha‐1‐antitrypsin (AAT)‐regulated, glucocorticoid receptor‐dependent genes in macrophages reveals a novel host defense function of AAT 2024 ·Physiological Reports ·Xiyuan Bai, Jun‐Feng Gao, (unknown), (unknown), (unknown), David E. Griffith, Bifeng Gao, Robert A. Sandhaus, Hua Huang, Edward D. Chan	1
3	Cardiovascular disease in adults with osteogenesis imperfecta: clinical characteristics, care recommendations, and research priorities identified using a modified Delphi technique 2024 ·Journal of Bone and Mineral Research ·Lars Folkestad, Siddharth K. Prakash, Sandesh C.S. Nagamani, N.H. Andersen, Erin M. Carter, Jannie Dahl Hald, (unknown), Bente Langdahl, Eleanor M. Perfetto, Cathleen Raggio, Stuart H. Ralston, Robert A. Sandhaus, Oliver Semler, Laura L. Tosi, Eric Orwoll	0
4	Clinical trial attitudes among individuals with Alpha-1 antitrypsin deficiency 2024 ·Respiratory Medicine ·Kristen E. Holm, Robert A. Sandhaus, (unknown), Charlie Strange	1
5	Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD 2024 ·International Journal of COPD ·Paul Ellis, Emily J Bailey, Radmila Choate, Kristen E. Holm, Robert A. Sandhaus, Alice Turner, Michael Newnham	1
6	Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence 2023 ·Biochemical Society Transactions ·Xiyuan Bai, Tony Schountz, Ashley M. Buckle, Janet Talbert, Robert A. Sandhaus, Edward D. Chan	9
7	Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease 2022 ·EBioMedicine ·Karina A. Serban, Katherine Pratte, Charlie Strange, Robert A. Sandhaus, Alice Turner, (unknown), Daniella A. Spittle, Lisa A. Maier, Nabeel Hamzeh, Edwin K. Silverman, Brian D. Hobbs, Craig P. Hersh, Dawn L. DeMeo, (unknown), Russell P. Bowler	10
8	Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin Deficiency 2022 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Radmila Choate, Robert A. Sandhaus, Kristen E. Holm, David M. Mannino, Charlie Strange	2
9	Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency 2017 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·(unknown), Michael G. Janech, Alexander V. Alekseyenko, Carl Atkinson, Harvey O. Coxson, Jeremy L. Barth, Sarah Stephenson, Carole L. Wilson, Lynn M. Schnapp, Alan R. Barker, Mark Brantly, Robert A. Sandhaus, Edwin K. Silverman, James K. Stoller, Bruce C. Trapnell, Charlie Strange	7
10	The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult 2016 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Robert A. Sandhaus, Gerard Turino, Mark Brantly, Michael Campos, Carroll E. Cross, Kenneth W. Goodman, D. Kyle Hogarth, Shandra L. Knight, James Stocks, James K. Stoller, Charlie Strange, Jeffrey Teckman	140
11	Integrated safety across six clinical trials of alpha-1 augmentation therapy 2014 ·European Respiratory Journal ·Robert A. Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, James Stocks, Jonathan M. Edelman, Martin Bexon, Liping Huang, Noel G. McElvaney	2
12	Baseline Patient Demographics and Lung Density Decline in the RAPID Trial 2014 ·CHEST Journal ·James Stocks, Robert A. Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, Liping Huang, Jonathan M. Edelman, Noel G. McElvaney	1
13	Neutrophil Elastase-Mediated Lung Disease 2013 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Robert A. Sandhaus, Gerard Turino	75
14	Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha ₁ -Proteinase Inhibitor (Human), Intravenous) 2013 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Robert A. Sandhaus, James Stocks, Farshid N. Rouhani, Mark Brantly, (unknown)	15
15	Prospective impact of illness uncertainty on outcomes in chronic lung disease. 2013 ·Health Psychology ·Karin F. Hoth, Frederick S. Wamboldt, Matthew Strand, Dee W. Ford, Robert A. Sandhaus, Charlie Strange, David B. Bekelman, Kristen E. Holm	28
16	The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status 2013 ·Journal of Behavioral Medicine ·Kristen E. Holm, (unknown), Dee W. Ford, Robert A. Sandhaus, Matthew Strand, Charlie Strange, Frederick S. Wamboldt	34
17	Effects of a Disease Management Program in Individuals with Alpha-1 Antitrypsin Deficiency 2009 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Michael Campos, (unknown), Guoyan Zhang, Adam Wanner, Robert A. Sandhaus	38
18	Multi-Center Study: The Biochemical Efficacy, Safety and Tolerability of a New α₁-Proteinase Inhibitor, Zemaira 2006 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·James Stocks, Mark Brantly, (unknown), Alan R. Barker, Friedrich Kueppers, Charlie Strange, James F. Donohue, Robert A. Sandhaus	40
19	COMPARABLE PHARMACOKINETIC PROPERTIES OF TWO ALPHA1-PROTEINASE INHIBITORS AFTER SINGLE THERAPEUTIC DOSES 2005 ·CHEST Journal ·James Stocks, Mark Brantly, Alan R. Barker, Friedrich Kueppers, Charlie Strange, James F. Donohue, Robert A. Sandhaus	2
20	Occupational Exposure Risks in Individuals with PIZ α1-Antitrypsin Deficiency 2000 ·American Journal of Respiratory and Critical Care Medicine* ·Annyce Mayer, James K. Stoller, Becki Bucher Bartelson, A. James Ruttenber, Robert A. Sandhaus, Lee S. Newman	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact